甜菊醇
糖苷
生产(经济)
生物生产
糖
食品科学
化学
生物化学
生物技术
生物
有机化学
经济
甜菊苷
替代医学
病理
宏观经济学
医学
作者
Bryant Luu,Shota Atsumi
标识
DOI:10.1016/j.copbio.2025.103333
摘要
To combat the rise in caloric overconsumption, new ways of satisfying sweet desires must reduce caloric intake without sacrificing palatability. Rare sugars and steviol glycosides are emerging classes of naturally occurring alternative sweeteners. They have gained interest for industrial production due to their low-calorie content, desirable flavor, and notable bioactivity for potential broader applications. Microbial production offers unique benefits to efficiently produce rare sugars and steviol glycosides. Particularly, the model organism Escherichia coli is capable of irreversible rare sugar production using phosphorylation-dephosphorylation chemistry using its native components. Saccharyomyces cerevisiae, another model organism, has emerged as an alternative production platform for producing various steviol glycosides. Herein, we summarize the chemical and enzymatic production pathways that establish microbial sweetener production.
科研通智能强力驱动
Strongly Powered by AbleSci AI